Med hensyn til leverinsufficiens bemærkede CHMP, at størstedelen af valsartan elimineres, hovedsageligt som uforandret lægemiddel i galden via leverclearance.
Regarding hepatic impairment, the CHMP noted that the majority of valsartan is eliminated, mainly as unchanged drug in the bile, through hepatic clearance.